- Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "Paradox"2009 | First Faculty of Medicine, Third Faculty of Medicine
- Renal Function, Assessed Using Cystatin C, and Antiplatelet Efficacy of Clopidogrel Assessed Using the Vasodilator-Stimulated Phosphoprotein Index in Patients Having Percutaneous Coronary Intervention2012 | Third Faculty of Medicine
- Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease2013 | Third Faculty of Medicine
- Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures2009 | First Faculty of Medicine, Third Faculty of Medicine
- High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial2009 | First Faculty of Medicine, Third Faculty of Medicine
- A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction2010 | Third Faculty of Medicine
- Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness2010 | First Faculty of Medicine, Third Faculty of Medicine
- Severe Left Ventricular Systolic Dysfunction is Independently Associated with High On-Clopidogrel Platelet Reactivity2014 | Third Faculty of Medicine
- High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel2012 | Third Faculty of Medicine